Nurturing biotech ventures

.

BioElevate

Turning early-stage health innovation into commercial direction

You’ve generated something novel in the lab. You may have recently filed — or will be preparing to file — a patent. Now comes the harder question: how does this become a real-world solution?

BioElevate is a two-day intensive designed for researchers who are new to commercialisation and ready to take their first structured step from discovery toward real-world impact.

7-8 May 2026 at Jumar Bioincubator, Melbourne

Apply now

Why BioElevate?

.
Over two in-person days, you will:

  • Clearly define and articulate your unmet clinical need

  • Identify your critical stakeholders and decision-makers

  • Develop a strong, defensible value proposition

  • Understand market segmentation and early opportunity sizing (TAM/SAM/SOM)

  • Map revenue streams and commercial pathways

  • Gain practical clarity on regulation, IP positioning, and funding options

  • Build your first structured pitch narrative

  • Test your pitch with experienced VCs in a closed-door session designed for honest, constructive feedback.

Apply now

You don’t need a company, ABN, or finished product, just a compelling idea and the drive to take it further.

.

Who is it for?

BioElevate is designed for founders, researchers, or early-stage teams in:

+ Therapeutics

+ Medtech

+ Diagnostics

+ Software as a Medical Device (SaMD)

.

Eligibility

To be eligible to participate in Elevate, you must:

+ Be actively developing a technology or solution

+ Have filed or thinking to file a patent

+ Be at early Technology Readiness Level (typically TRL 1–3)

Be new to commercialisation and ready to engage in the process

How it works

Find the right fit

Tell us your idea and where are you at

Assessment

We review your application and invite successful applicants to join

Get ready

Complete onboarding and online prep

Elevate workshops

Dive into a fast-paced, hands on experience

Stay connected

Post-program support and opportunities

Meet the Facilitators

.

Dr Patricia Vietheer
Senior Director, R&D Strategy & Planning at Biointelect

At Biointelect, Patricia leads the R&D Strategy & Planning team, supporting a wide range of clients from universities, research institutions, government, start-up companies, biotech, medtech and pharma companies. She has led numerous projects at Biointelect in commercialisation strategy, business case development, planning and execution for key clients. She is particularly passionate about helping clients streamline their path to market using strategic project management techniques and thus commercialising their novel discoveries.

.

A/Prof Daryl Cheng
Consultant Paediatrician, Department of General Medicine at The Royal Children’s Hospital Melbourne

At Biointelect, Patricia leads the R&D Strategy & Planning team, supporting a wide range of clients from universities, research institutions, government, start-up companies, biotech, medtech and pharma companies. She has led numerous projects at Biointelect in commercialisation strategy, business case development, planning and execution for key clients. She is particularly passionate about helping clients streamline their path to market using strategic project management techniques and thus commercialising their novel discoveries.

Guest Speakers

.
Ian Rourke, PhD Partner at FB Rice
.
Betty Zhang Investment Manager at Boson Ventures
.
Dr Ingmar Wahlqvist Acting Chief Commercialisation Officer and leads the Monash Ventures team at Monash Innovation
.
Dr Joey Man Investment Associate at Tenmile
.
Founder TBC

Places are limited.

Early applications are strongly encouraged! Places are limited and interest is high. If you have an idea with the potential to make a real impact, now is the time to take the next step.

Apply for BioElevate today and start turning your ideas into something tangible.

Apply now